Skip to main content

Advertisement

Log in

Is There a Need for an Exogenous Activator Along with PRP for Early Knee Osteoarthritis? A Triple-Blinded Randomized Control Trial

  • Original Article
  • Published:
Indian Journal of Orthopaedics Aims and scope Submit manuscript

Abstract

Background

In addition to other variables associated with PRP injections for Knee Osteoarthritis (OA), some confusion exists about the role of exogenous activators. The current study looks at matched groups getting PRP injections with or without activator (Calcium gluconate) in early knee OA patients.

Methods

Patients of early OA knee meeting inclusion criteria were randomly divided into 2 groups; Group A (43 patients) received 8 ml PRP injection alone, and Group B (48 patients) received 8 ml PRP along with 2 ml Calcium gluconate as activator. The patients were evaluated at baseline, 6 weeks, 3 months and 6 months for WOMAC Pain and Total WOMAC scores; secondary variables assessed were VAS score and patient satisfaction.

Results

The baseline characteristics of both groups were comparable. Leucocyte-depleted PRP with 5 times concentration and average absolute platelet numbers of 7.144 billion per knee was injected. Mean Pain WOMAC scores decreased in both groups from baseline (group A—8.68, group B—9.09) to final follow-up (group A—4.67, group B—5.11). Similarly, Mean Total WOMAC scores decreased from baseline (group A—37.81, group B—37.41) to (group A—21, group B—21.36) at the final follow-up in both groups. There was no significant difference between both groups, and both showed similar trends. Similar findings were noted for VAS scores. Patient satisfaction was also not different (group A, 90.69%, group B, 89.58%) at the end of 6 months.

Conclusion

Our study concluded doubtful role of adding exogenous activator to PRP preparation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

Not applicable.

Code Availability

Not applicable.

References

  1. Wearing, S. C., Hennig, E. M., Byrne, N. M., Steele, J. R., & Hills, A. P. (2006). Musculoskeletal disorders associated with obesity: A biomechanical perspective. Obesity Reviews: Official Journal of the International Association for the Study of Obesity, 7(3), 239–250.

    Article  CAS  Google Scholar 

  2. Langworthy, M. J., Saad, A., & Langworthy, N. M. (2010). Conservative treatment modalities and outcomes for osteoarthritis: The concomitant pyramid of treatment. The Physician and Sportsmedicine, 38(2), 133–145.

    Article  PubMed  Google Scholar 

  3. Pietrzak, W. S., & Eppley, B. L. (2005). Platelet rich plasma: Biology and new technology. The Journal of Craniofacial Surgery, 16(6), 1043–1054.

    Article  PubMed  Google Scholar 

  4. Patel, S., Dhillon, M. S., Aggarwal, S., Marwaha, N., & Jain, A. (2013). Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: A prospective, double-blind, randomized trial. American Journal of Sports Medicine, 41(2), 356–364.

    Article  PubMed  Google Scholar 

  5. Görmeli, G., Görmeli, C. A., Ataoglu, B., Çolak, C., Aslantürk, O., & Ertem, K. (2017). Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: A randomized, double-blind, placebo-controlled trial. Knee Surgery, Sports Traumatology, Arthroscopy, 25(3), 958–965.

    Article  PubMed  Google Scholar 

  6. Li, M., Zhang, C., Ai, Z., Yuan, T., Feng, Y., & Jia, W. (2011). Therapeutic effectiveness of intra-knee-articular injection of platelet-rich plasma on knee articular cartilage degeneration. Journal of Reparative and Reconstructive Surgery, 25(10), 1192–1196.

    Google Scholar 

  7. Filardo, G., Kon, E., Pereira Ruiz, M. T., Vaccaro, F., Guitaldi, R., Di Martino, A., et al. (2012). Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: Single- versus double-spinning approach. Knee Surgery, Sports Traumatology, Arthroscopy, 20(10), 2082–2091.

    Article  PubMed  Google Scholar 

  8. Duymus, T. M., Mutlu, S., Dernek, B., Komur, B., Aydogmus, S., & Kesiktas, F. N. (2017). Choice of intra-articular injection in treatment of knee osteoarthritis: Platelet-rich plasma, hyaluronic acid or ozone options. Knee Surgery, Sports Traumatology, Arthroscopy, 25(2), 485–492.

    Article  PubMed  Google Scholar 

  9. Spaková, T., Rosocha, J., Lacko, M., Harvanová, D., & Gharaibeh, A. (2012). Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. American Journal of Physical Medicine and Rehabilitation, 91(5), 411–417.

    Article  PubMed  Google Scholar 

  10. Raeissadat, S. A., Rayegani, S. M., Hassanabadi, H., Fathi, M., Ghorbani, E., Babaee, M., et al. (2015). Knee osteoarthritis injection choices: Platelet- rich plasma (prp) versus hyaluronic acid (A one-year randomized clinical trial). Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 8, 1–8.

    PubMed  PubMed Central  Google Scholar 

  11. Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. Journal of Pharmacology and Pharmacotherapeutics, 1(2), 100–107.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., et al. (1986). Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis & Rheumatology, 29 (8), 1039–49.

  13. Kohn, M. D., Sassoon, A. A., & Fernando, N. D. (2016). Classifications in brief: Kellgren-Lawrence classification of osteoarthritis. Clinical Orthopaedics, 474(8), 1886–1893.

    Article  Google Scholar 

  14. Tubach, F., Wells, G. A., Ravaud, P., & Dougados, M. (2005). Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: Methodological issues. Journal of Rheumatology, 32(10), 2025–2029.

    PubMed  Google Scholar 

  15. Kon, E., Mandelbaum, B., Buda, R., Filardo, G., Delcogliano, M., Timoncini, A., et al. (2011). Platelet-rich plasma intra-articular injection versus hyaluronic acid visco supplementation as treatments for cartilage pathology: From early degeneration to osteoarthritis. Arthroscopy, 27(11), 1490–1501.

    Article  PubMed  Google Scholar 

  16. Chang, K.-V., Hung, C.-Y., Aliwarga, F., Wang, T.-G., Han, D.-S., & Chen, W.-S. (2014). Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: A systematic review and meta-analysis. Archives of Physical Medicine and Rehabilitation, 95(3), 562–575.

    Article  PubMed  Google Scholar 

  17. Laudy, A. B. M., Bakker, E. W. P., Rekers, M., & Moen, M. H. (2015). Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: A systematic review and meta-analysis. British Journal of Sports Medicine, 49(10), 657–672.

    Article  PubMed  Google Scholar 

  18. Shen, L., Yuan, T., Chen, S., Xie, X., & Zhang, C. (2017). The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: Systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Surgery, 12, 16.

    Article  Google Scholar 

  19. Cavallo, C., Roffi, A., Grigolo, B., Mariani, E., Pratelli, L., Merli, G., et al. (2016). Platelet-Rich plasma: The choice of activation method affects the release of bioactive molecules. BioMed Research International, 2016, 6591717.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Mishra, A., Harmon, K., Woodall, J., & Vieira, A. (2012). Sports medicine applications of platelet-rich plasma. Current Pharmaceutical Biotechnology, 13(7), 1185–1195.

    Article  CAS  PubMed  Google Scholar 

  21. DeLong, J. M., Russell, R. P., & Mazzocca, A. D. (2012). Platelet-rich plasma: The PAW classification system. Arthroscopy, 28(7), 998–1009.

    Article  PubMed  Google Scholar 

  22. Patel, S., Gahlaut, S., Thami, T., Chouhan, D. K., Jain, A., & Dhillon, M. S. (2024). Comparison of conventional dose versus superdose platelet-rich plasma for knee osteoarthritis: A prospective, triple-blind, randomized clinical trial. Orthopaedic Journal of Sports Medicine, 12(2), 23259671241227864.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Bansal, H., Leon, J., Pont, J. L., Wilson, D. A., Bansal, A., Agarwal, D., et al. (2021). Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long-term clinical efficacy. Science and Reports, 11(1), 3971.

    Article  CAS  Google Scholar 

  24. Chouhan, D. K., Dhillon, M. S., Patel, S., Bansal, T., Bhatia, A., & Kanwat, H. (2019). Multiple platelet- rich plasma injections versus single platelet-rich plasma injection in early osteoarthritis of the knee: An experimental study in a guinea pig model of early knee osteoarthritis. American Journal of Sports Medicine, 47(10), 2300–2307.

    Article  PubMed  Google Scholar 

  25. Dhillon, M. S., Patel, S., & Bansal, T. (2019). Improvising PRP for use in osteoarthritis knee- upcoming trends and futuristic view. Journal of Clinical Orthopaedics and Trauma, 10(1), 32–35.

    Article  PubMed  Google Scholar 

  26. Kon, E., Buda, R., Filardo, G., Di Martino, A., Timoncini, A., Cenacchi, A., et al. (2010). Platelet-rich plasma: Intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surgery, Sports Traumatology, Arthroscopy, 18(4), 472–479.

    Article  PubMed  Google Scholar 

Download references

Funding

No funding was required.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sandeep Patel.

Ethics declarations

Conflict of Interest

On behalf of all authors, the corresponding author would like to declare there are no potential conflicts of interest.

Ethics Approval

This kind of study does not require ethical approval.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 814 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rai, S., Patel, S., Chouhan, D.K. et al. Is There a Need for an Exogenous Activator Along with PRP for Early Knee Osteoarthritis? A Triple-Blinded Randomized Control Trial. JOIO (2024). https://doi.org/10.1007/s43465-024-01159-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s43465-024-01159-7

Keywords

Navigation